zorevunersen (STK-001)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
An Open-Label Extension Study of STK-001 for Patients With Dravet SyndromeNCT04740476STOKPhase 2Active not recruiting2029-03-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.